New mRNA vaccines could be a critical tool to fight cancer. But their future is up in the air

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

HIV's earliest immune battle leaves blood traces that forecast powerful antibodies years later

Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, ...
Frontiers

Real-world advances in inflammatory diseases: from population data to immunological mechanisms and clinical impact

Inflammatory diseases contain a broad spectrum of immune-mediated conditions, including autoimmune, autoinflammatory, allergic, dermatologic, ...
Frontiers

Systems Immunoengineering in Cancer: Decoding and Reprogramming Tumor–Immune Ecosystems

Cancer immunology is advancing rapidly as researchers seek to unravel the complex, dynamic relationships between tumor cells, immune populations, and the ...
Business Wire

EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology

SAN MATEO, Calif.--(BUSINESS WIRE)--EpiBiologics, a leader in tissue-selective extracellular protein degradation, today announced the completion of a $107 million Series B financing co-led by GV ...
IFLScience

Natural Selection Shaped Hundreds More Human Genes Than We Thought, Massive Ancient DNA Study Finds

Scientists previously thought only a handful of genes showed signs of selection in recent human evolution, but previous ...
The Scientist

Gene Editing Turns the Immune System into a Custom Protein Factory

Researchers used CRISPR to edit hematopoietic stem cells, creating B cells that produce neutralizing antibodies against HIV, ...

Programming the immune system to manufacture its own therapeutic proteins

An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...
Healio

Q&A: Review outlines peanut allergy management advances PCPs, pediatricians should know

In the last 10 years, several advancements in peanut allergy management have emerged, including Palforzia, omalizumab and ...
Business Insider

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

CAMBRIDGE, Mass. and WALTHAM, Mass., March 31, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced the companies have entered into a ...
Yahoo Finance

Johnson & Johnson’s JNJ-4804 Deal Adds Weight To Immunology Story

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CNBC

Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week

Novartis' acquisition of U.S.-based Excellergy will add an early-stage drug candidate Exl-111 to the company's existing allergy portfolio. It comes just a week after Novartis announced it is acquiring ...